-
Uncategorized2 months agoSpyre drug for inflammatory bowel disease shows promise in early study
The therapy, which works similarly to Takeda’s blockbuster Entyvio, showed remission rates that suggest a “best-in-class” profile, the company said.
-
Uncategorized2 months agoRevolution pancreatic cancer drug nearly doubles survival in key trial
The subject of buyout rumors this year, Revolution posted Phase 3 results one analyst called a “game changer” in a tough-to-treat tumor. Read More
-
Uncategorized2 months ago
Allogene’s first cut of data on ‘off-the-shelf’ CAR-T shows promise
Allogene Therapeutics’ CAR-T therapy removed all remaining detectable lymphoma cells in just over half of treated patients, according to an early look at the Phase 2...
-
Uncategorized2 months ago
Regeneron wades into radiopharma through $40M upfront deal with Telix
Regeneron is set to work on radiopharmaceuticals for the first time in a new partnership to develop solid tumor therapies as well as diagnostic agents with...
-
Uncategorized2 months ago
Neural Mechanism Underlying Sensory Behavior Revealed in C. elegans
Animal behavior reflects a complex interplay between an animal’s brain and its sensory surroundings. In a new study published in Nature Neuroscience titled, “Neural sequences underlying directed turning in Caenorhabditis elegans,”...
-
Uncategorized2 months ago
FDA urges clinical trial sponsors to report the results of their studies
An FDA review of records found that results have not been reported for 30% of registered clinical studies. To remedy this shortfall, the U.S. regulator has...
-
Uncategorized2 months agoReAlta secures $40m to advance peptide for newborn brain injury
ReAlta Life Sciences has announced the closing of an oversubscribed $40 million financing, bringing the total capital raised to date to more than $150 million. The...
-
Uncategorized2 months agoSTAT+: GSK advancing ovarian cancer drug mo-rez
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. It’s been a minute since...
-
Uncategorized2 months ago
Light makes plants stronger but also holds them back
Light doesn’t just help plants grow—it may also quietly hold them back. Researchers have uncovered a surprising mechanism where light strengthens the “glue” between a plant’s...
-
Uncategorized2 months ago
Revolution Medicines’ pancreatic cancer drug doubles survival time in Phase 3
Revolution Medicines reported Monday that its experimental KRAS inhibitor called daraxonrasib succeeded in a registrational trial for pancreatic cancer. And now, the company plans to ask...
STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
